Related Experiment Video
Updated: May 31, 2026
13:22
Adhesion Frequency Assay for In Situ Kinetics Analysis of Cross-Junctional Molecular Interactions at the Cell-Cell Interface
Published on: November 2, 2011
Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell
Lauren T May1, Lloyd J Bridge, Leigh A Stoddart
1Institute of Cell Signalling, School of Biomedical Sciences, The University of Nottingham, Nottingham, UK, NG7 2UH.
Summary
G-protein-coupled receptors (GPCRs) often form dimers, and this study reveals significant cooperativity at the A(3) adenosine receptor dimer interface. This finding enhances understanding of drug action specificity in living cells.
Area of Science:
- Pharmacology
- Molecular Biology
- Biophysics
Background:
- Many G-protein-coupled receptors (GPCRs) function as homodimers.
- The extent of functional cooperativity across GPCR homodimer interfaces remains largely unexplored.
Purpose of the Study:
- To investigate the cooperativity between protomers of human A(1) and A(3) adenosine receptors within a dimer.
- To explore the impact of orthosteric ligands on the dissociation kinetics of a fluorescent agonist from these receptor dimers in living cells.
Main Methods:
- Measurement of dissociation kinetics of a fluorescent agonist (ABA-X-BY630) from A(1) and A(3) adenosine receptors in CHO-K1 cells.
- Assessment of ligand-induced changes in agonist dissociation rates in the presence of various orthosteric agonists and antagonists.
- Analysis of pEC(50) values for ligands binding to the ABA-X-BY630-occupied A(3)-receptor dimer.
Main Results:
- Evidence of highly cooperative interactions between protomers of the A(3)-receptor dimer was observed.
- Dissociation of ABA-X-BY630 from A(3) receptors was significantly modulated (increased 9-19 fold) by orthosteric ligands, unlike A(1) receptors (1.4-1.5 fold).
- Co-expression of a nonbinding A(3)-receptor mutant reduced ABA-X-BY630 dissociation, further supporting dimer cooperativity.
Conclusions:
- This study provides novel insights into the allosteric modulation across GPCR homodimeric interfaces.
- The findings highlight the spatial and temporal specificity of drug action mediated by GPCR dimer cooperativity.
- Understanding GPCR dimer function is crucial for developing targeted therapeutics.
Related Concept Videos
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...